DJIA 17,828.24 0.49 0.00%
NASDAQ 4,791.63 4.31 0.09%
S&P 500 2,067.56 -5.27 -0.25%
market minute promo

NxStage Medical (NASDAQ: NXTM)

17.28 -0.31 (-1.76%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

NXTM $17.28 -1.76%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $17.35
Previous Close $17.59
Daily Range $17.09 - $17.72
52-Week Range $9.39 - $17.87
Market Cap $1.1B
P/E Ratio -43.98
Dividend (Yield) $0.00 (0.0%)
Volume 148,528
Average Daily Volume 558,422
Current FY EPS -$0.41




Healthcare Information Services

NxStage Medical (NXTM) Description

A medical device company, which develops, manufactures and markets innovative systems for the treatment of end-stage renal disease and acute kidney failure. Website:

News & Commentary

Why NxStage Medical Inc. Stock Surged Higher

Medical device maker NxStage filters out the pessimists and rockets higher by as much as 13% after reporting better-than-expected third-quarter earnings results and lifting its full-year sales forecast.

NxStage Medical (NXTM) Upgraded From Sell to Hold

NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog

NxStage Medical Unveils Streamline Express Dialyzer - Analyst Blog

Update: NxStage Medical Q3 2014 Earnings

How to Uncover Institutional Buying - Screen of the Week

NxStage Medical's (NXTM) CEO Jeff Burbank on Q3 2014 Results - Earnings Call Transcript

Benzinga's Volume Movers

Mid-Morning Market Update: Markets Edge Lower; DirecTV Profit Tops Estimates

NxStage Medical (NXTM) Q3 2014 Results - Earnings Call Webcast

Commit To Purchase NxStage Medical At $12.50, Earn 14.1% Annualized Using Options

See More NXTM News...

NXTM's Top Competitors

NXTM $17.28 (-1.76%)
Current stock: NXTM
$0.00 (0.00%)
Current stock:
MDT $73.87 (0.53%)
Current stock: MDT
COV $101.00 (0.46%)
Current stock: COV